Global Prothrombin Complex Concentrate (PCC) Market to be Driven by the Growth of the Healthcare Industry in the Forecast Period of 2021-2026.
M2 PRESSWIRE-July 30, 2021-IMARC (Expert Market Research): Global Prothrombin Complex Concentrate (PCC) Market to be Driven by the Growth of the Healthcare Industry in the Forecast Period of 2021-2026
(C)1994-2021 M2 COMMUNICATIONS
RDATE:30072021
The new report by EMR titled, 'Global Prothrombin Complex Concentrate (PCC) Market Report and Forecast 2021-2026', gives an in-depth analysis of the global prothrombin complex concentrate (PCC) market, assessing the market based on its segments like product, application, end use and major regions like North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter's Five Forces models.
Get a Free Sample Report with Table of Contents -https://www.expertmarketresearch.com/reports/prothrombin-complex-concentrate-pcc-market/requestsample
The key highlights of the report include:
Market Overview (2016-2026)
Forecast CAGR (2021-2026): 9%
Due to its clinical value against fresh frozen plasma (FPP)., PCC is expected to have a substantial increase. When compared to FFP, PCC requires less volume and infusion time and is more efficient. Blood matching and thawing like FFP are also not necessary for PCC. It is also anticipated that the widespread use of Vitamin K antagonists such as warfarin would drive robust PCC industry development. Adult patients undergoing vitamin K antagonist therapy may have developed coagulation factor deficiency, according to the FDA. The urgent reversal for such can be achieved with the indication of PCC, Kcentra, in case of acute bleeding. It is expected that hemophilic patients will rise in number over the coming years. Their therapy requires PCC, which will raise demand further.
Industry Definition and Major Segments
Prothrombin complex concentrate (PCC) is derived from human plasma and used as a drug containing blood clotting. It is used to avoid bleeding in the treatment of hemophilia. When acute bleeding occurs, vitamin K antagonist therapy also accompanies the use of PCC. This is listed in the list of essential medicines needed in the health system of the World Health Organisation as one of the safest and most effective medicines.
Based on the product, the industry is divided into:
3-Factor PCC
4-Factor PCC
Based on the...
To continue reading
Request your trial